Home > Insider Trading > Filing (0001181431-12-060629)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1401923	Map Pharmaceuticals Inc.	MAPP	Pharmaceutical Preparations (2834)	200507047

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1236451	Geraldine Henwood	C/O Map Pharmaceuticals, Inc. 2400 Bayshore Parkway, Suite 200 Mountain View CA 94043		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-11-23	1,490	$0.74	1,490	No	4	M	Direct
Common Stock	Disposition	2012-11-23	1,490	$15.00	0	No	4	S	Direct
Common Stock	Acquisiton	2012-11-23	3,750	$3.18	3,750	No	4	M	Direct
Common Stock	Disposition	2012-11-23	3,750	$15.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2012-11-23	1,490	$0.00	0	$0.74
Common Stock	Stock Option	Disposition	2012-11-23	3,750	$0.00	0	$3.18

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2016-12-01	No	4	M	Direct
0		2019-05-20	No	4	M	Direct

Footnotes

The sale of the reported shares is made pursuant to terms of 10b5-1 plan in effect at the time of sale of the shares.
The option is exercisable as it vests: 1/12th of the total number of option shares becomes exercisable cumulatively each month following the grant date over the following 12 months, so that the entire number of option shares will become fully vested and exercisable on the one year anniversary from the grant date on the condition that vesting continue while the director remains a member of the board of directors of the issuer.